UA41928C2 - Похідні оксазолідину, спосіб їх одержання, фармацевтична композиція та спосіб її одержання, спосіб лікування захворювань - Google Patents

Похідні оксазолідину, спосіб їх одержання, фармацевтична композиція та спосіб її одержання, спосіб лікування захворювань

Info

Publication number
UA41928C2
UA41928C2 UA95114761A UA95114761A UA41928C2 UA 41928 C2 UA41928 C2 UA 41928C2 UA 95114761 A UA95114761 A UA 95114761A UA 95114761 A UA95114761 A UA 95114761A UA 41928 C2 UA41928 C2 UA 41928C2
Authority
UA
Ukraine
Prior art keywords
preparation
oxazolidine
derivatives
diseases
treatment
Prior art date
Application number
UA95114761A
Other languages
English (en)
Russian (ru)
Inventor
Йоахім Ганте
Йоахим ГАНТЕ
Хорст Юрасцук
Петер РАДДАТЦ
Ханнс Вурцігер
Ханнс ВУРЦИГЕР
Сабіне Бернотат-Даніловські
Сабине Бернотат-Даниловськи
Гвідо Мельцер
Гвидо Мельцер
Original Assignee
Мерк Патент Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мерк Патент Гмбх filed Critical Мерк Патент Гмбх
Publication of UA41928C2 publication Critical patent/UA41928C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

Похідні оксазолідину формули (I): де Х означає О, S, NH або NA Y означає заміщений за допомогою R2 азирідиновий, азетидіновий, піролідиновий, піперидиновий, гексагідроазеіновий або піперазиновий залишок R1 означає R2 означає -CrH2r-COOR3, R3 означає Н, А або Аr, А означає алкіл з 1-6 C атомами, В означає Н, А, циклоалкіл з 3-7 C атомами, Аr-СkH2k або амідино-групу, Аr означає незаміщений або одно- або дворазово заміщений за допомогою А, Сl, Вr, I, NO2, CN, ОА, ОН, NH2, NHA і/або NA2 фенильний або бензильний залишок, "k" означає 1, 2, 3 або 4, "m" і "r" кожен, незалежно один від одного, означають 0,1, 2, 3 або 4, і "n" означає 2, 3 або 4, а також їх фізіологічно прийнятні солі.
UA95114761A 1994-11-08 1995-11-01 Похідні оксазолідину, спосіб їх одержання, фармацевтична композиція та спосіб її одержання, спосіб лікування захворювань UA41928C2 (uk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4439846A DE4439846A1 (de) 1994-11-08 1994-11-08 Adhäsionsrezeptor-Antagonisten

Publications (1)

Publication Number Publication Date
UA41928C2 true UA41928C2 (uk) 2001-10-15

Family

ID=6532768

Family Applications (1)

Application Number Title Priority Date Filing Date
UA95114761A UA41928C2 (uk) 1994-11-08 1995-11-01 Похідні оксазолідину, спосіб їх одержання, фармацевтична композиція та спосіб її одержання, спосіб лікування захворювань

Country Status (22)

Country Link
US (1) US5776937A (uk)
EP (1) EP0711770A1 (uk)
JP (1) JPH08208629A (uk)
KR (1) KR100384978B1 (uk)
CN (1) CN1069640C (uk)
AR (1) AR002245A1 (uk)
AU (1) AU704184B2 (uk)
BR (1) BR9505109A (uk)
CA (1) CA2162223A1 (uk)
CO (1) CO4520229A1 (uk)
CZ (1) CZ291049B6 (uk)
DE (1) DE4439846A1 (uk)
FI (1) FI955351A (uk)
HU (1) HU217085B (uk)
NO (1) NO306113B1 (uk)
PL (1) PL183595B1 (uk)
RU (1) RU2155762C2 (uk)
SK (1) SK281815B6 (uk)
TR (1) TR199501389A2 (uk)
TW (1) TW316903B (uk)
UA (1) UA41928C2 (uk)
ZA (1) ZA959434B (uk)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0710657T3 (da) * 1994-11-02 1999-05-25 Merck Patent Gmbh Adhæsionsreceptor-antagonister
US6046331A (en) * 1998-12-17 2000-04-04 Synaptic Pharmaceutical Corporation Imidazolones and their use in treating benign prostatic hyperplasia and other disorders
AU2593600A (en) 1998-12-23 2000-07-12 G.D. Searle & Co. Method of using a cyclooxygenase-2 inhibitor and a matrix metalloproteinase inhibitor as a combination therapy in the treatment of neoplasia
EP1147422A1 (en) 1999-01-27 2001-10-24 Pharmacia & Upjohn Company Assays for modulators of "elongation factor p" activity
AU2003275480A1 (en) * 2002-10-07 2004-05-04 Smithkline Beecham Corporation Compounds
CN102796091A (zh) * 2011-05-24 2012-11-28 北大方正集团有限公司 取代的噁唑烷酮化合物及其制备方法和应用
JP6216385B2 (ja) * 2012-10-29 2017-10-18 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ ３，４−二置換オキサゾリジノン誘導体及びカルシウム活性化カリウムチャネルの阻害薬としてのそれらの使用
CN104230915B (zh) * 2014-08-29 2016-08-17 南京大学 含噻唑烷二酮的苯基哌嗪衍生物及其制备方法与用途
KR20240135687A (ko) 2017-06-20 2024-09-11 임브리아 파마슈티칼스, 인크. 심장 대사의 효율을 증가시키기 위한 조성물 및 방법
US11780811B2 (en) 2020-06-30 2023-10-10 Imbria Pharmaceuticals, Inc. Methods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
US11530184B2 (en) 2020-06-30 2022-12-20 Imbria Pharmaceuticals, Inc. Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
US11883396B2 (en) 2021-05-03 2024-01-30 Imbria Pharmaceuticals, Inc. Methods of treating kidney conditions using modified forms of trimetazidine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3723797A1 (de) * 1987-07-18 1989-01-26 Merck Patent Gmbh Oxazolidinone
US5053393A (en) * 1988-07-20 1991-10-01 Monsanto Company Novel platelet-aggregation inhibitor
US5084466A (en) * 1989-01-31 1992-01-28 Hoffmann-La Roche Inc. Novel carboxamide pyridine compounds which have useful pharmaceutical utility
DE4005371A1 (de) * 1990-02-21 1991-08-22 Merck Patent Gmbh Oxazolidinone
DE4017211A1 (de) * 1990-05-29 1991-12-05 Merck Patent Gmbh Oxazolidinone
DE4405633A1 (de) * 1993-05-01 1994-11-03 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
DE4332384A1 (de) * 1993-09-23 1995-03-30 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten III

Also Published As

Publication number Publication date
US5776937A (en) 1998-07-07
AR002245A1 (es) 1998-03-11
PL183595B1 (pl) 2002-06-28
CN1132201A (zh) 1996-10-02
CZ291049B6 (cs) 2002-12-11
NO954458D0 (no) 1995-11-07
NO306113B1 (no) 1999-09-20
ZA959434B (en) 1996-05-15
CN1069640C (zh) 2001-08-15
AU3661895A (en) 1996-05-23
DE4439846A1 (de) 1996-05-09
PL311257A1 (en) 1996-05-13
CZ288895A3 (en) 1996-06-12
HUT76052A (en) 1997-06-30
HU217085B (hu) 1999-11-29
SK281815B6 (sk) 2001-08-06
HU9503191D0 (en) 1996-01-29
FI955351A0 (fi) 1995-11-07
BR9505109A (pt) 1997-09-09
CA2162223A1 (en) 1996-05-09
NO954458L (no) 1996-05-09
FI955351A (fi) 1996-05-09
CO4520229A1 (es) 1997-10-15
KR100384978B1 (ko) 2003-09-02
JPH08208629A (ja) 1996-08-13
SK136895A3 (en) 1996-06-05
TR199501389A2 (tr) 1996-07-21
KR960017663A (ko) 1996-06-17
TW316903B (uk) 1997-10-01
RU2155762C2 (ru) 2000-09-10
EP0711770A1 (de) 1996-05-15
AU704184B2 (en) 1999-04-15

Similar Documents

Publication Publication Date Title
HK1003708A1 (en) Peripheral vasodilating agent containing n-acylated 4-amino piperidine derivatives as active ingredients
DE69923849D1 (de) Quinolin-2-on-derivate verwendbar als antikrebsmittel
UA41928C2 (uk) Похідні оксазолідину, спосіб їх одержання, фармацевтична композиція та спосіб її одержання, спосіб лікування захворювань
CA2121253A1 (en) Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics
DE69420564D1 (de) Immunsuppressive und antiallergische verbindungen; z.b. n-(3-oxohexanoyl)-homoserinlacton
NO996108L (no) 9-oksinerytromycinderivater
HUT42072A (en) Process for production of new derivatives of quinolin, izoquinolin and quinasoline and medical preparatives containing of these new compounds
DK645688D0 (da) 3-(4-(1-substitueret 4-piperazinyl)butyl)-4-thiazolidinoner, deres fremstilling og anvendelse
NO943093L (no) Fremgangsmåte for fremstilling av clavulansyre
PT928788E (pt) Compostos farmaceuticamente activos
NO20015172L (no) 1-metyl-erytromycin-derivater
NO984878L (no) Fremstilling og anvendelse som medikamenter av 3-alkoksypyridin-2-karboksylsyreamidestere
GB9408185D0 (en) New benzamide derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
DZ1694A1 (fr) "n-(2-Aminoethyl)-benzothialozones".
DK0849269T3 (da) Vinylpyrrolidincephalosporiner med basiske substituenter
DE69828317D1 (de) Verfahren zur Herstellung von N-((4-Phenyl)methylphenyl)piperazinen
IE890177L (en) Piperidinyl derivatives
HUT58709A (en) Process for producing n-aryl-piperazin-acetamide derivatives and pharmaceutical compositions containing them
ES2012648A6 (es) Procedimiento para la preparacion de nuevos derivados de 1,4-benzoxazina y 1,4-benzotiazina.
BG101220A (en) N-substituted 3-azabicyclo (93.2.0) heptane derivatives,their preparation and use
HUP0203275A2 (hu) 1-(Gyűrűs amino)-alkilciklohexán-származékok, ezeket tartalmazó görcsoldó hatású gyógyszerkészítmények, valamint ezek alkalmazása
HUT70052A (en) Process for producing pharmaceutical compositions containing pirimidone derivatives in the treatment of certain airway or skin diseases
DK0506434T3 (da) Thiazolidinon- og oxazolidinon-derivater, fremstilling deraf og deres anvendelse som vasodilaterende midler
RU1795966C (ru) Способ получени производных дитрет-бутиловых эфиров 3,4-оксибензоилоксипропаноламинов
DK0427518T3 (da) NMDA-blokerende forbindelser, farmaceutiske præparater, deres fremstilling og anvendelse